Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Whellan, David

< Back

Profile

djw150

David J. Whellan, MD, MHS, FACC, FAHA

Contact Dr. Whellan

1015 Chestnut Street
Suite 317
Philadelphia, PA 19107

(215) 955-2636
(215) 503-7420 fax

Medical School

MD, Washington University School of Medicine
Master Health Science in Clinical Research, Duke University

Residency

Hospital of University of Pennsylvania (HUP)

Fellowship

Clinical Cardiology, Duke University Medical Center

Board Certification

Internal Medicine
Cardiovascular Disease

Hospital Appointment

Thomas Jefferson University Hospital

Expertise & Research Interests

Dr. Whellan is the Principal Investigator of Jefferson Regional Clinical Center for the NIH HF Network, one of 9 centers across the United States selected to participate in a series of novel heart failure clinical trials. In addition, he serves as the Associate Provost for Clinical Research at Thomas Jefferson University and Associate Dean for Clinical Research at Sidney Kimmel Medical College.

He has authored over 175 peer-reviewed articles, reviews, abstracts, and book chapters on cardiomyopathy; and is an associate editor for the Journal of the American College of Cardiology Heart Failure journal.

Publications

Most Recent Peer-Reviewed Publications

  1. Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012
  2. Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized with Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure with Reduced and Preserved Left Ventricular Ejection Fraction
  3. Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial
  4. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk
  5. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers
  6. Effect of early intervention with positive airway pressure therapy for sleep disordered breathing on six-month readmission rates in hospitalized patients with heart failure
  7. Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study
  8. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial
  9. Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds
  10. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias
  11. Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations from the Heart Failure Society of America Guideline Committee
  12. Erratum: Corrigendum to exercise training for chronic heart failure (ExTraMATCH II): Protocol for an individual participant data meta-analysis (Int J Cardiol. (2014) 174:3 (683-687) DOI: http://dx.doi.org/10.1016/j.ijcard.2014.04.203)
  13. Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial
  14. Team-Based Care for Managing Cardiac Comorbidities in Heart Failure
  15. Photoplethysmographic Signal to Screen Sleep-Disordered Breathing in Hospitalized Heart Failure Patients: Feasibility of a Prospective Clinical Pathway
  16. Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure
  17. Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure
  18. Evaluation of the incremental prognostic utility of increasingly complex testing in chronic heart failure
  19. Exercise training as therapy for heart failure current status and future directions
  20. Authorship in a multicenter clinical trial: The heart failure - A controlled trial investigating outcomes of exercise training (HF-ACTION) authorship and publication (HAP) scoring system results